• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aratana Therapeutics Inc

+ Add to Watchlist

PETX:US

11.7500 USD 0.3300 2.73%

As of 20:10:00 ET on 08/22/2014.

Snapshot for Aratana Therapeutics Inc (PETX)

Open: 12.0700 Day's Range: 11.6100 - 12.0700 Volume: 122,375
Previous Close: 12.0800 52wk Range: 8.0701 - 29.3200 1-Yr Rtn: +32.92%

Stock Chart for PETX

No chart data available.
  • PETX:US 11.7500
  • 1D
  • 1M
  • 1Y
12.0800
Interactive PETX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PETX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4907
Est. EPS (USD) (12/2014) -1.5130
Est. PEG Ratio -
Market Cap (M USD) 346.01
Shares Outstanding (M) 29.45
30 Day Average Volume 166,589
Price/Book (mrq) 2.1129
Price/Sale (ttm) 515.9096
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PETX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PETX

Aratana Therapeutics, Inc. develops biomedical therapeutics for animals. The Company offers products to treat the pain and inflammation associated with osteoarthritis in pets. Aratana Therapeutics markets its products in the United States.

Steven St PeterPresident/CEO/Co-FounderCraig A ToomanCFO/Treasurer
Ernst HeinenChief Development OfficerLinda RhodesChief Scientific Officer
More Company Profile & Key Executives for PETX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • PETX News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil